Laboratory diagnosis of human herpesvirus 8 infection in humans

被引:19
作者
Tedeschi, R
Dillner, J
Paoli, P
机构
[1] IRCCS, Ctr Riferimento Oncol, Microbiol Immunol & Virol Dept, I-33081 Aviano, Italy
[2] MAS Univ Hosp, Dept Med Microbiol, S-20502 Malmo, Sweden
关键词
D O I
10.1007/s10096-002-0836-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Human herpesvirus 8 (HHV-8) is causally associated with Kaposi's sarcoma, primary effusion lymphoma and multicentric Castleman's disease. Serological and molecular biology assays are used to investigate the biology of this virus in different populations and diseases. Serological assays are mainly used to study the prevalence of the viral infection and to predict the diagnosis of Kaposi's sarcoma and other HHV-8-associated cancers. The appearance of antibodies against lytic antigens precedes the appearance of antibodies against latent antigens, probably explaining the lower sensitivity of assays based on latent HHV-8 antigens. The lack of international reference serum panels is presently the major bottle-neck for further progress in the field of HHV-8 serology. Molecular biological assays are an absolute requirement for both the diagnosis and the follow-up of HHV-8 infection. Qualitative methods have been particularly useful to elucidate the mode of transmission and the causal association between HHV-8 and HHV-8-associated diseases. Quantitative methods have become an essential tool to monitor the progression of the infection and the effects of antiviral therapies. This review analyzes the performance of the different serological and molecular biological assays available at present. The main conclusion is that more research is needed to define the most useful laboratory tests for the diagnosis of HHV-8 infection and to establish the clinical role of such tests.
引用
收藏
页码:831 / 844
页数:14
相关论文
共 137 条
[41]  
3.0.CO
[42]  
2-E
[43]   Exacerbations of clinical symptoms in human immunodeficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells [J].
Grandadam, M ;
Dupin, N ;
Calvez, V ;
Gorin, I ;
Blum, L ;
Kernbaum, S ;
Sicard, D ;
Buisson, Y ;
Agut, H ;
Escande, JP ;
Huraux, JM .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1198-1201
[44]   Two distinct gamma-2 herpesviruses in African green monkeys: A second gamma-2 herpesvirus lineage among old world primates? [J].
Greensill, J ;
Sheldon, JA ;
Renwick, NM ;
Beer, BE ;
Norley, S ;
Goudsmit, J ;
Schulz, TF .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1572-1577
[45]   KSHV strains: the origins and global spread of the virus [J].
Hayward, GS .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) :187-199
[46]   Real time quantitative PCR [J].
Heid, CA ;
Stevens, J ;
Livak, KJ ;
Williams, PM .
GENOME RESEARCH, 1996, 6 (10) :986-994
[47]   Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate [J].
Hjalgrim, H ;
Frisch, M ;
Melbye, M .
BRITISH JOURNAL OF CANCER, 1998, 78 (03) :419-420
[48]   Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors [J].
Howard, MR ;
Whitby, D ;
Bahadur, G ;
Suggett, F ;
Boshoff, C ;
TenantFlowers, M ;
Schulz, TF ;
Kirk, S ;
Matthews, S ;
Weller, IVD ;
Tedder, RS ;
Weiss, RA .
AIDS, 1997, 11 (02) :F15-F19
[49]   Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients [J].
Hudnall, SD ;
Rady, PL ;
Tyring, SK ;
Fish, JC .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1791-1794
[50]   New immunofluorescence assays for detection of human herpesvirus 8-specific antibodies [J].
Inoue, N ;
Mar, EC ;
Dollard, SC ;
Pau, CP ;
Zheng, Q ;
Pellett, PE .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2000, 7 (03) :427-435